Skip to search.
 Dow Up 0.18% Nasdaq Up 0.69%

Abbott Laboratories Common Stoc (ABT)

-NYSE

57.04 Up 0.44(0.78%) 4:01PM EST|After Hours: 56.84 Down 0.20 (0.35%) 7:54PM EST

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2011Sep 30, 2011Jun 30, 2011Mar 31, 2011
Total Revenue 10,377,453   9,816,665   9,616,291   9,040,850  
Cost of Revenue3,837,875  3,973,250  3,870,472  3,858,983  
Gross Profit 6,539,578   5,843,415   5,745,819   5,181,867  
Operating Expenses
Research Development1,151,607  1,009,627  1,037,780  930,400  
Selling General and Administrative2,905,503  4,238,910  2,762,086  2,850,318  
Non Recurring400,000   -  172,500  100,000  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 2,082,468   594,878   1,773,453   1,301,149  
Income from Continuing Operations
Total Other Income/Expenses Net(2,677)31,056  35,232  (86,776)
Earnings Before Interest And Taxes2,079,791  625,934  1,808,685  1,214,373  
Interest Expense126,086  124,339  134,129  145,587  
Income Before Tax1,953,705  501,595  1,674,556  1,068,786  
Income Tax Expense335,037  198,414  (268,226)204,968  
Minority Interest -   -   -   -  
Net Income From Continuing Ops1,618,668  303,181  1,942,782  863,818  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,618,668   303,181   1,942,782   863,818  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 1,618,668   303,181   1,942,782   863,818  

Currency in USD.